Share
Trueinvivo exhibited (and attended) the International Conference on Dosimetry and its Applications (ICDA-2) at the University of Surrey from 3rd to 8th July 2016. There was great interest in the micro silica beads and their potential use. The company also made very good international connections and is in the process of signing a Memorandum of Understanding (MOU) with another organisation.
Related Posts
TRUEinvivo's 2018 achievements include prototype development, patent filings, fundraising, multiple awards, and market expansion, setting the stage for a busy 2019.
Dr. Shakardokht Jafari presents DOSEmapper™ at IPEM conference after ESTRO, highlighting glass beads' innovation in dosimetry.
TRUEinvivo joined SyndicateRoom investment platform in February 2019, leveraging its network to connect with potential investors, alongside Nexus Investment Ventures Ltd,
TRUEinvivo's DOSEmapper™ technology receives enthusiastic feedback from industry leaders at ESTRO37 conference.
